Lilly Ventures has spun out from drugmaker Eli Lilly & Co., in order to offer its employees more competitive compensation packages, according to VentureWire. As part of the deal, Lilly Ventures secured a new $200 million capital commitment from its former parent company. www.lillyventures.com

Related posts:

  1. Lilly Backs BioVeda
  2. Lilly Closes Hypnion Purchase
  3. Lilly and Transpharma Sign Deal
  4. Altea Deals with Lilly and Amylin Pharma
  5. MacroGenics Signs Deal with Lilly